Navigation Links
IDEXX Laboratories Announces First Quarter Results
Date:4/24/2009

88-0329 and reference confirmation code 996071. An audio replay will be available through May 1, 2009 by dialing 320-365-3844 and referencing replay code 996071.

The call will also be available via live or archived Webcast on the IDEXX Laboratories' web site at www.idexx.com.

Annual Meeting

IDEXX Laboratories, Inc. today announced that it will host a simultaneous Webcast of its Annual Meeting of Stockholders, to be held on Wednesday, May 6, 2009, at 10:00 a.m. (eastern) at the Portland Marriott at Sable Oaks in South Portland, Maine.

Chairman and CEO, Jonathan Ayers will chair the meeting. Investors may listen to the Annual Meeting and view a presentation live via a link on the Company's web site, www.idexx.com. An archived edition of the meeting will be available after 1:00 p.m. (eastern) on that day via the same link.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,700 people and offers products to customers in over 100 countries.

Note Regarding Forward-Looking Statements

This press release contains statements about the Company's business prospects and estimates of the Company's financial results for future periods that are forward-look
'/>"/>

SOURCE IDEXX Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
2. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
3. IDEXX Laboratories Announces Fourth Quarter Results
4. IDEXX Laboratories Announces Increase in Share Repurchase Program
5. IDEXX Laboratories to Release 2008 First Quarter Financial Results
6. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
7. IDEXX Laboratories Names William Brown Corporate Vice President
8. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
9. IDEXX Laboratories Announces Fourth Quarter and Full Year Results
10. IDEXX Laboratories to Release 2009 First Quarter Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... young athletes are under increasing pressure to p...a University Health System study of 519 junior ten...reases the risk of injury. Researchers who analyze...n junior competition found that players who specia...from tournaments for medical reasons, typically in...
(Date:11/8/2009)...Newswire-USNewswire/ -- Jon O,Brien, president of ...nt about the passage of HR 3962: ,, "Behavior ... lot about core values. We in the prochoice commun...rcome the struggles ordinary Americans have making...afford basic healthcare or have to choose between ...
(Date:11/8/2009)...ition promotes self-assurance, research finds , ...mother may have been right when she told you to si...ture could make you feel more confident about your...ing up straight gives a good impression to other p...a psychology professor at Ohio State University, s...
(Date:11/8/2009)...Newswire-USNewswire/ -- Speaker Nancy Pelosi and D...g the House passage of H.R. 3962, the Affordable H...vote of 220 to 215. Below are the Speaker,s openi...st received a call from the President of the Unite...at victory for the American people. I thank the Pr...
(Date:11/8/2009)...eeze-drying of biopharmaceuticals to be available ...ty. , Toronto, ON (PRWEB...d CEO of Therapure Biopharma Inc. today announced ...l scale pharmaceutical grade freeze dryer and expe...lization) available for contract manufacturing of ...
Breaking Medicine News(10 mins):Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2
...o receive a vaccine to protect them against severe... are less likely to contract a serious disease, ac...rvard Medical School studied more than 740 childre... -- a bacterium that causes a person to become res...
...snapshot of the nation's health, put together by t...ws that nearly a third of Americans are obese //an...rth continues to rise, reaching a new record high ...om 1990. The life expectancy for boys born in 2001...
...with men and cars? Why doesn't he notice how much ...ep a grip on the remote control? And the most bewi...me? The answers, says social philosopher Michae...the technology to prove it. "What Could He Be T...
...and its symptoms have been shown to accelerate dea...ooked at the elderly in particular. // A new s...g in the community and not in assisted-living faci...e presence of depression and then did so again at ...
...e tells us high heeled shoes are not good for the ...that assumption. British researchers find no relat...opment of knee osteoarthritis.// About 2 perce... has led investigators to speculate a lifetime of ...
...a popular herbal supplement thought to have anti-c...sical and mental abilities, and help people cope w...rly used by pregnant women, particularly in Asian ...f pregnant women were taking herbal supplements, i...
Other Medicine News:Health News:Diabetes, obesity rates shooting up 2Health News:How a man's mind really works 2
(Date:11/6/2009)...e-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin B...ta-based, biopharmaceutical company developing hum...munodeficiency Virus) and other infectious agents,...results and provided an operational update. ,, ...ve Officer commented, "We are pleased with our pro...
(Date:11/6/2009)...e-FirstCall/ -- Caraco Pharmaceutical Laboratories...romethamine ophthalmic solution, 0.5% following a ...ation (FDA) for Sun Pharma,s Abbreviated New Drug ...mic solution on the first day following patent exp...ally equivalent to Acular® Ophthalmic Solutio...
(Date:11/6/2009)...ewswire/ -- , - Trial Will Compare NXL103...nt of Multi-Resistant Staphylococcus Aureus (MRSA)...aceutical company focused on the discovery and,dev... the significant global,problem of microbial resis...,antibacterial NXL103 (flopristin/linopristin), ha...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4New Complimentary Wallet Card to Tackle Concussions Head On 58903 1New Complimentary Wallet Card to Tackle Concussions Head On 58903 2CTIA West Wireless Health Institute Qualcomm and CommNexus San Diego Present 3A San Diego The Nations Hub for Wireless Healthcare 58900 1CTIA West Wireless Health Institute Qualcomm and CommNexus San Diego Present 3A San Diego The Nations Hub for Wireless Healthcare 58900 2Verenium Announces Proposed Public Offering of Common Stock 14359 1Verenium Announces Proposed Public Offering of Common Stock 14359 2Verenium Announces Proposed Public Offering of Common Stock 14359 3
...ESS WIRE)--Jun 11, 2007 - Opexa,Therapeutics, Inc....ent and commercialization of cell therapies, made ...f the Federation of,Clinical Immunology Societies ... Diego Hotel & Marina. The poster, entitled,"I...elapsing,Remitting Multiple Sclerosis Patients" wa...
...tudy Presented at Federation of,Clinical Immunolog...lif., June 11, 2007 /PRNewswire-FirstCall/ --,Orch...nounced today,positive new data from its completed...estigational T Cell Receptor (TCR) peptide,vaccine... sclerosis,(MS). The new data, presented last week...
Other Medicine Technology:Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5
Shandon Pathcentre Netmon Service
Shandon Excelsior Tissue Processor
Shandon Gross-Star Grossing Workbench
Shandon Hyperclean 20 Fume Handling Station
Medicine Products: